A polyketone composition includes: (A) a polyketone having, in a main chain, a structural unit represented by the following Formula (I); and (B) an epoxy compound. In Formula (I), X represents a bivalent group that has from 1 to 50 carbon atoms and that may have a substituent group, Y represents a bivalent hydrocarbon group that has from 1 to 30 carbon atoms and that may have a substituent group, and n represents an integer from 1 to 1500. ##STR00001##

A method of making a metal organic framework (MOF)-polymer composite material includes forming a homogeneous solution comprising a solvent, a metal salt, a polymer which is soluble in the solvent, and a reactant which can be synthesized to provide an organic linker during formation of a MOF structure, synthesizing the homogeneous solution to crystallize a MOF structure in the homogenous solution to yield the MOF structure distributed in a remainder solution, applying an antisolvent to the remainder solution with the MOF structure distributed in the remainder solution to form a polymer-rich phase, where the MOF structure is integrated into the polymer matrix during forming of the polymer matrix to produce a MOF-polymer composite material. The MOF-polymer composite material can be formed on a substrate to produce a MOF structured object, which can be a membrane, film, or other object.

The present disclosure relates to a composition that includes a first repeat unit that includes

##STR00001##

where x is between 1 and 1,000, inclusively, and R.sub.1 includes at least one of a first hydrocarbon chain and/or a first hydrocarbon ring. In some embodiments of the present disclosure, R.sub.1 may further include at least one of an oxygen atom, a nitrogen atom, a sulfur atom, and/or a phosphorus atom.

The present disclosure relates to a composition that includes a first repeat unit that includes

##STR00001##

where x is between 1 and 1,000, inclusively, and R.sub.1 includes at least one of a first hydrocarbon chain and/or a first hydrocarbon ring. In some embodiments of the present disclosure, R.sub.1 may further include at least one of an oxygen atom, a nitrogen atom, a sulfur atom, and/or a phosphorus atom.

A polyketone composition contains: a polyketone containing a structural unit represented by the following Formula (I), and inorganic particles; in which a content of the inorganic particle is from 10 parts by mass to 70 parts by mass, based on 100 parts by mass of a total amount of the polyketone and the inorganic particles, and an average particle diameter of the inorganic particles is from 10 nm to 200 nm. In Formula (I), each X independently represents a bivalent group that has from 1 to 50 carbon atoms and that may have a substituent group, each Y independently represents a bivalent hydrocarbon group that has from 1 to 30 carbon atoms and that may have a substituent group, and n represents an integer from 1 to 1,500

##STR00001##

A polyketone composition contains: a polyketone containing a structural unit represented by the following Formula (I), and inorganic particles; in which a content of the inorganic particle is from 10 parts by mass to 70 parts by mass, based on 100 parts by mass of a total amount of the polyketone and the inorganic particles, and an average particle diameter of the inorganic particles is from 10 nm to 200 nm. In Formula (I), each X independently represents a bivalent group that has from 1 to 50 carbon atoms and that may have a substituent group, each Y independently represents a bivalent hydrocarbon group that has from 1 to 30 carbon atoms and that may have a substituent group, and n represents an integer from 1 to 1,500

##STR00001##

A monomer having formula (I):

##STR00001##

wherein in formula (I), groups and variables are the same as described in the specification.

A monomer having formula (I):

##STR00001##

wherein in formula (I), groups and variables are the same as described in the specification.

A sterilizable medical packaging with living pores according to this invention is made of a specific blend of polyolefin polymers and additives wherein during the production process, the mixture is extruded to form a fine heterophasic substrate film comprising a rigid tough phase of a very fine crystalline lattice network which contributes to the strengthening and toughening of the film substrate, and a soft elastic phase of dispersing amorphous domains which fulfills the crystalline network thoroughly. Under pressure in sterilization process, these amorphous regions will enlarge their interstitial volumes, enabling the sub-micrometer pores to allow for gas phase sterilant to permeate through the packaging to sterilize the medical products inside, and these living pores will close automatically when the packaging is removed from the sterile chambers into a common atmosphere. Without any open dead pore structure, but by having a balance set of heterophase structures and some hydrophilic additives, this novel packaging can undergo all common sterilization methods, especially by ethylene oxide or steam, so that the film is ideally used for sterile medical packaging with an excellent microbial barrier that distinctly ensure product's sterility and prolong its shelf life, even in a poor storage condition.

A sterilizable medical packaging with living pores according to this invention is made of a specific blend of polyolefin polymers and additives wherein during the production process, the mixture is extruded to form a fine heterophasic substrate film comprising a rigid tough phase of a very fine crystalline lattice network which contributes to the strengthening and toughening of the film substrate, and a soft elastic phase of dispersing amorphous domains which fulfills the crystalline network thoroughly. Under pressure in sterilization process, these amorphous regions will enlarge their interstitial volumes, enabling the sub-micrometer pores to allow for gas phase sterilant to permeate through the packaging to sterilize the medical products inside, and these living pores will close automatically when the packaging is removed from the sterile chambers into a common atmosphere. Without any open dead pore structure, but by having a balance set of heterophase structures and some hydrophilic additives, this novel packaging can undergo all common sterilization methods, especially by ethylene oxide or steam, so that the film is ideally used for sterile medical packaging with an excellent microbial barrier that distinctly ensure product's sterility and prolong its shelf life, even in a poor storage condition.